Development of therapeutic peptide producers based on <i>Escherichia coli</i> BL21 and their cultivation technology

Introduction. Peptides with a molecular weight of less than 5 kDa have been used in medicine and biotechnology over the past decade for the treatment of various diseases. However, chemical synthesis peptide has several disadvantages, including low yield, reduced efficiency, and high costs. An altern...

Full description

Saved in:
Bibliographic Details
Main Authors: Z. R. Khasanshina, I. A. Kornakov, E. A. Buslaeva, A. V. Kazakova, S. A. Ishchuk, V. I. Shmurak, V. B. Saparova, V. F. Latypov, R. V. Drai
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2025-03-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/2023
Tags: Add Tag
No Tags, Be the first to tag this record!